HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rafał Krygier Selected Research
Rafał Krygier Research Topics
Disease
7
Infections
01/2023 - 01/2020
4
Chronic Hepatitis C
12/2022 - 05/2021
3
Coinfection
03/2024 - 10/2020
3
Fibrosis (Cirrhosis)
05/2021 - 03/2020
2
HIV Infections (HIV Infection)
01/2022 - 05/2021
1
Hepatocellular Carcinoma (Hepatoma)
03/2024
1
Hepatitis C
01/2022
1
End Stage Liver Disease
05/2021
1
Liver Diseases (Liver Disease)
05/2021
1
Proteinuria
01/2021
1
Chronic Hepatitis B
01/2011
Drug/Important Bio-Agent (IBA)
6
Antiviral Agents (Antivirals)
IBA
01/2023 - 01/2021
2
Interferons
IBA
05/2021 - 01/2020
1
sofosbuvir drug combination ledipasvir
IBA
01/2022
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
05/2021
1
Calcineurin Inhibitors
IBA
01/2021
1
Creatinine
IBA
01/2021
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
10/2020
1
dasabuvir
IBA
03/2020
1
ombitasvir
IBA
03/2020
1
Ritonavir (Norvir)
FDA Link
03/2020
1
paritaprevir
IBA
03/2020
1
Hepatitis B e Antigens
IBA
01/2011
1
Lamivudine (Epivir)
FDA Link
01/2011
1
adefovir dipivoxil (Hepsera)
FDA Link
01/2011
Therapy/Procedure
4
Therapeutics
01/2022 - 01/2020
1
Liver Transplantation
03/2024
1
Aftercare (After-Treatment)
01/2021
1
Kidney Transplantation
01/2021
1
Renal Dialysis (Hemodialysis)
01/2021
1
Duration of Therapy
03/2020